Dr ADNAN  MANSOOR, FRCPC - University of Calgary - Professor

Dr ADNAN MANSOOR

FRCPC

University of Calgary

Professor

CALGARY, AB | Canada

Main Specialties: Pathology-Anatomic & Clinical

Additional Specialties: Hematopathology

Dr ADNAN  MANSOOR, FRCPC - University of Calgary - Professor

Dr ADNAN MANSOOR

FRCPC

Introduction

Primary Affiliation: University of Calgary - CALGARY, AB , Canada

Specialties:

Additional Specialties:

Research Interests:


View Dr ADNAN MANSOOR’s Resume / CV

Publications

39Publications

1227Reads

268Profile Views

286PubMed Central Citations

Acute myeloid leukaemia: expression of MYC protein and its association with cytogenetic risk profile and overall survival.

Hematol Oncol 2017 Sep 8;35(3):350-356. Epub 2016 Feb 8.

Department of Pathology & Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2279DOI Listing
September 2017
124 Reads
3.084 Impact Factor

Concomitant high expression of Toll-like receptor (TLR) and B-cell receptor (BCR) signalling molecules has clinical implications in mantle cell lymphoma.

Hematol Oncol 2017 Mar 10;35(1):79-86. Epub 2015 Sep 10.

Division of Hematology and Transfusion Medicine, Department of Pathology and Laboratory Medicine, University of Calgary/Calgary Laboratory Services (CLS), Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2251DOI Listing
March 2017
27 Reads
6 Citations
3.084 Impact Factor

De Novo Acute Myeloid Leukemia in Adults: Suppression of MicroRNA-223 is Independent of LMO2 Protein Expression BUT Associate With Adverse Cytogenetic Profile and Undifferentiated Blast Morphology.

Appl Immunohistochem Mol Morphol 2015 Nov-Dec;23(10):733-9

*Calgary Laboratory Services (CLS), Department of Pathology & Laboratory Medicine, Division of Hematology & TM ‡Calgary Laboratory Services (CLS), Department of Pathology & Laboratory Medicine, Division of Anatomic Pathology, University of Calgary, Calgary, AB, Canada †Department of Pathology and Laboratory Medicine (GE) and Oncology (AMA), Prince Sultan Military Medical City, Riyadh, Saudi Arabia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0000000000000145DOI Listing
August 2016
27 Reads

Protein Expression for Novel Prognostic Markers (Cyclins D1, D2, D3, B1, B2, ITGβ7, FGFR3, PAX5) Correlate With Previously Reported Gene Expression Profile Patterns in Plasma Cell Myeloma.

Appl Immunohistochem Mol Morphol 2015 May-Jun;23(5):327-33

Department of Pathology & Laboratory Medicine, Division of Hematology and Transfusion Medicine, University of Calgary/Calgary Laboratory Services (CLS), Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0000000000000089DOI Listing
February 2016
48 Reads
1 Citation

PARP1 expression in mantle cell lymphoma: the utility of PARP1 immunohistochemistry and its relationship with markers of DNA damage.

Hematol Oncol 2015 Dec 20;33(4):159-65. Epub 2014 Aug 20.

Department of Pathology & Laboratory Medicine, University of Calgary/Calgary Laboratory Services, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2160DOI Listing
December 2015
29 Reads
3.084 Impact Factor

CD10-positive mantle cell lymphoma: biologically distinct entity or an aberrant immunophenotype? Insight, through gene expression profile in a unique case series.

J Clin Pathol 2015 Oct 29;68(10):844-8. Epub 2015 Jun 29.

Division of Hematology and Transfusion Medicine, Department of Pathology and Laboratory Medicine, University of Calgary/Calgary Laboratory Services (CLS), Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2015-202955DOI Listing
October 2015
11 Reads
3 Citations
2.920 Impact Factor

Performance of the CellaVision(®) DM96 system for detecting red blood cell morphologic abnormalities.

J Pathol Inform 2015 24;6:11. Epub 2015 Feb 24.

Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB T2L 2K8, Canada ; Calgary Laboratory Services, Calgary, AB T2L 2K8, Canada.

View Article

Download full-text PDF

Source
http://www.jpathinformatics.org/text.asp?2015/6/1/11/151922
Publisher Site
http://dx.doi.org/10.4103/2153-3539.151922DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355826PMC
March 2015
60 Reads
1 Citation

Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system.

J Neurooncol 2015 Jan 13;121(2):289-96. Epub 2014 Nov 13.

Division of Hematology and Transfusion Medicine, Department of Pathology and Laboratory Medicine, University of Calgary/Calgary Laboratory Services (CLS), Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-014-1655-3DOI Listing
January 2015
58 Reads
5 Citations
3.070 Impact Factor

Results of a prospective phase II trial evaluating interim positron emission tomography-guided high dose therapy for poor prognosis diffuse large B-cell lymphoma.

Leuk Lymphoma 2014 Sep 17;55(9):2064-70. Epub 2014 Feb 17.

Medicine and Oncology, University of Calgary , Calgary , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.862242DOI Listing
September 2014
14 Reads
5 Citations

B-lymphoblastic leukemia/lymphoma: overexpression of nuclear DNA repair protein PARP-1 correlates with antiapoptotic protein Bcl-2 and complex chromosomal abnormalities.

Hum Pathol 2014 Aug 18;45(8):1582-7. Epub 2014 Apr 18.

Department of Pathology & Laboratory Medicine, University of Calgary and Calgary Laboratory Services (CLS), Calgary, Alberta, Canada T2N 2T9. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2013.11.024DOI Listing
August 2014
36 Reads
3 Citations
2.770 Impact Factor

Accuracy of the CellaVision DM96 platform for reticulocyte counting.

J Pathol Inform 2014 26;5(1):17. Epub 2014 May 26.

Department of Pathology and Laboratory Medicine, Division of Hematology and Transfusion Medicine, Calgary Laboratory Services, University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/2153-3539.133127DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060401PMC
July 2014
27 Reads

Immune cell subset counts associated with graft-versus-host disease.

Biol Blood Marrow Transplant 2014 Apr 6;20(4):450-62. Epub 2014 Jan 6.

Department of Medicine, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.01.002DOI Listing
April 2014
37 Reads
14 Citations
3.404 Impact Factor

LMO2 (LIM domain only 2) is expressed in a subset of acute myeloid leukaemia and correlates with normal karyotype.

Histopathology 2014 Jan 6;64(2):226-33. Epub 2013 Nov 6.

Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.12242DOI Listing
January 2014
10 Reads
1 Citation
3.453 Impact Factor

Expression of MS4A and TMEM176 Genes in Human B Lymphocytes.

Front Immunol 2013 15;4:195. Epub 2013 Jul 15.

Department of Biochemistry and Molecular Biology, Snyder Institute for Chronic Diseases, University of Calgary , Calgary, AB , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2013.00195DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711070PMC
July 2013
50 Reads
11 Citations

Performance of CellaVision DM96 in leukocyte classification.

J Pathol Inform 2013 29;4:14. Epub 2013 Jun 29.

Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, T2L 2K8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/2153-3539.114205DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709426PMC
July 2013
29 Reads
7 Citations

Reovirus modulates autophagy during oncolysis of multiple myeloma.

Autophagy 2013 Mar 15;9(3):413-4. Epub 2013 Jan 15.

Department of Oncology, University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/auto.22867DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590261PMC
March 2013
29 Reads
18 Citations
11.753 Impact Factor

Reovirus as a viable therapeutic option for the treatment of multiple myeloma.

Clin Cancer Res 2012 Sep 3;18(18):4962-72. Epub 2012 Jul 3.

Department of Oncology, University of Calgary, Calgary, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-3085DOI Listing
September 2012
34 Reads
21 Citations
8.722 Impact Factor

Bortezomib-induced "BRCAness" sensitizes multiple myeloma cells to PARP inhibitors.

Blood 2011 Dec 13;118(24):6368-79. Epub 2011 Sep 13.

Division of Hematology and Bone Marrow Transplant, University of Calgary, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2011-06-363911DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348156PMC
December 2011
7 Reads
41 Citations
10.452 Impact Factor

NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series.

Blood 2011 Feb 21;117(5):1447-52. Epub 2010 Oct 21.

Department of Pathology & Laboratory Medicine/Calgary Laboratory Services, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-08-302737DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056587PMC
February 2011
17 Reads
21 Citations
10.452 Impact Factor

Quantification of CD20 mRNA and protein levels in chronic lymphocytic leukemia suggests a post-transcriptional defect.

Leuk Res 2010 Dec 2;34(12):1670-3. Epub 2010 Aug 2.

Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2010.06.031DOI Listing
December 2010
18 Reads
7 Citations
2.351 Impact Factor

pY-STAT3 and p53 expression predict outcome for poor prognosis diffuse large B-cell lymphoma treated with high dose chemotherapy and autologous stem cell transplantation.

Leuk Lymphoma 2009 Aug;50(8):1276-82

Department of Oncology and Medicine, University of Calgary and Tom Baker Cancer Centre, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190903015628DOI Listing
August 2009
14 Reads
6 Citations

Mutation or polymorphism of the CD20 gene is not associated with the response to R-CHOP in diffuse large B cell lymphoma patients.

Leuk Res 2009 Jun 2;33(6):792-7. Epub 2008 Dec 2.

Calgary Laboratory Services, University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2008.10.013DOI Listing
June 2009
13 Reads
6 Citations
2.351 Impact Factor

Reliability of point-of-care testing of INR in acute stroke.

Can J Neurol Sci 2008 Jul;35(3):348-51

Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary, Foothills Hospital, Rm C1101A, 1403-29th Street NW, Calgary, Alberta T2N 2T9, Canada.

View Article

Download full-text PDF

Source
http://www.ucalgary.ca/quicr/files/quicr/s0317167100008945a.
Web Search
http://dx.doi.org/10.1017/s0317167100008945DOI Listing
July 2008
11 Reads
3 Citations
1.600 Impact Factor

Multiple lymphomatous diverticulosis and comorbid chronic lymphocytic leukemia: novel manifestations of ileocolic mantle cell lymphoma.

Int J Surg Pathol 2007 Oct;15(4):408-13

Department of Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1066896907302372DOI Listing
October 2007
7 Reads
0.961 Impact Factor

Cyclin D1 and t(11;14)-positive B-cell neoplasms resembling marginal zone B-cell lymphoma: a morphological variant of mantle cell lymphoma.

Hum Pathol 2007 May 20;38(5):797-802. Epub 2007 Feb 20.

Department of Laboratory Medicine and Pathology, University of Calgary and Calgary Laboratory Services, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2006.10.017DOI Listing
May 2007
8 Reads
1 Citation
2.770 Impact Factor

A definitive diagnosis of primary Hodgkin lymphoma on endoscopic biopsy material utilizing in-depth immunohistochemical analysis.

Can J Gastroenterol 2007 Mar;21(3):185-8

Department of Pathology and Laboratory Medicine, Peter Lougheed Centre, University of Calgary, Calgary, Canada.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2657687PMC
http://dx.doi.org/10.1155/2007/362360DOI Listing
March 2007
13 Reads
1.970 Impact Factor

Immunoglobulin VH somatic hypermutation in mantle cell lymphoma: mutated genotype correlates with better clinical outcome.

Mod Pathol 2006 Nov 15;19(11):1498-505. Epub 2006 Sep 15.

Department of Laboratory Medicine and Pathology, Cross Cancer Institute and University of Alberta, Edmonton, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.3800677DOI Listing
November 2006
14 Reads
6 Citations
6.190 Impact Factor

Ring chromosome 7 with amplification of 7q sequences in a pediatric case of hepatosplenic T-cell lymphoma.

Cancer Genet Cytogenet 2006 Jun;167(2):161-3

Department of Medical Genetics, Alberta Children's Hospital, 2888 Shaganappi Trail NW, Calgary, AB Canada T3B 6A8.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergencyto.2005.12.003DOI Listing
June 2006
9 Reads
2 Citations

Waldenstrom macroglobulinemia involving extramedullary sites: morphologic and immunophenotypic findings in 44 patients.

Am J Surg Pathol 2003 Aug;27(8):1104-13

Department of Hematopathology, University of Texas, MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00000478-200308000-00007DOI Listing
August 2003
11 Reads
3 Citations
5.145 Impact Factor

Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Clinicopathologic features of 12 cases.

Am J Clin Pathol 2003 Aug;120(2):246-53

Department of Hematopathology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://ajcp.oxfordjournals.org/content/ajcpath/120/2/246.ful
Web Search
http://dx.doi.org/10.1309/R01V-XG46-MFCD-VNHLDOI Listing
August 2003
27 Reads
12 Citations
2.514 Impact Factor

The stromal composition of malignant lymphoid aggregates in bone marrow: variations in architecture and phenotype in different B-cell tumours.

Br J Haematol 2002 Jun;117(3):569-76

Division of Pathology and Laboratory Medicine, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2141.2002.03497.xDOI Listing
June 2002
56 Reads
4 Citations
4.711 Impact Factor

Top co-authors

Douglas A Stewart
Douglas A Stewart

University of Calgary

10
Ariz Akhter
Ariz Akhter

University of Calgary

8
Meer-Taher Shabani-Rad
Meer-Taher Shabani-Rad

University of Calgary

8
Raymond Lai
Raymond Lai

University of Alberta

5
Joanne Luider
Joanne Luider

University of Calgary

5
Ghaleb Elyamany
Ghaleb Elyamany

Theodor Bilharz Research Institute

5
Payam Pournazari
Payam Pournazari

University of Calgary and Calgary Laboratory Services

5
Etienne Mahe
Etienne Mahe

McMaster University

4
Jan Storek
Jan Storek

University of Calgary

4